ERICA LITTLEFIELD: Open Payments
NPI 1063186120 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,427 in 121 payments from 20 companies in 2025. Trend: 2023 $1,278 · 2024 $2,272 · 2025 $2,427
Food & beverage: $2,427
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $556 |
| Madrigal Pharmaceuticals | 12 | $400 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $276 |
| Ardelyx, Inc. | 10 | $239 |
| Aimmune Therapeutics, Inc. | 11 | $178 |
| GENZYME CORPORATION | 5 | $151 |
| Janssen Biotech, Inc. | 5 | $99 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 6 | $63 |
| Lilly USA, LLC | 3 | $62 |
Products named: REZDIFFRA, DUPIXENT, IBSRELA, RINVOQ, XIFAXAN, SKYRIZI, VOWST, TREMFYA.
Industry payments across AL — which companies pay providers there.
